Bank Of New York Mellon Corp Seres Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$521 Trillion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.09 - $9.05 $1.27 Million - $2.25 Million	248,904 New	248,904 $1.39 Million
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $118,331 - $243,424	33,809 Added 15.87%	246,805 $1.59 Million
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.62 $33,831 - $95,478	-12,530 Reduced 5.56%	212,996 $730,000
Q1 2022 May 11, 2022	BUY	$6.3 - $8.84 $30,914 - $43,377	4,907 Added 2.22%	225,526 $1.61 Million
Q4 2021 Feb 11, 2022	SELL	$6.02 - $11.43 $322,256 - $611,859	-53,531 Reduced 19.53%	220,619 $1.84 Million

Q3 2021 Nov 12, 2021	BUY	$5.46 - $22.6 $74,059 - $306,546	13,564 Added 5.21%	274,150 $1.91 Million
Q2 2021 Aug 11, 2021	BUY	$18.46 - $24.36 $981,001 - $1.29 Million	53,142 Added 25.62%	260,586 $6.21 Million
Q1 2021 May 13, 2021	SELL	$17.66 - $28.92 $191,928 - $314,302	-10,868 Reduced 4.98%	207,444 $4.27 Million
Q4 2020 Feb 09, 2021	BUY	$23.25 - $37.73 $705,079 - $1.14 Million	30,326 Added 16.13%	218,312 $5.35 Million
Q3 2020 Nov 12, 2020	BUY	$3.74 - $28.74 $206,294 - $1.59 Million	55,159 Added 41.53%	187,986 $5.32 Million
Q2 2020 Aug 12, 2020	BUY	$3.04 - $6.2 $55,343 - $112,871	18,205 Added 15.88%	132,827 $632,000
Q1 2020 May 06, 2020	BUY	$2.64 - $3.82 $6,272 - $9,076	2,376 Added 2.12%	114,622 $409,000
Q4 2019 Feb 14, 2020	BUY	$2.99 - $4.42 $63,283 - $93,549	21,165 Added 23.24%	112,246 $387,000
Q3 2019 Nov 07, 2019	BUY	$2.29 - $4.16 $62,127 - $112,860	27,130 Added 42.42%	91,081 $365,000
Q2 2019 Aug 12, 2019	SELL	$2.28 - $7.35 $56,730 - $182,882	-24,882 Reduced 28.01%	63,951 $205,000
Q1 2019 May 14, 2019	BUY	$4.83 - $7.21 $16,755 - $25,011	3,469 Added 4.06%	88,833 $611,000
Q4 2018 Feb 11, 2019	BUY	$4.52 - $8.88 $27,223 - $53,484	6,023 Added 7.59%	85,364 $386,000
Q2 2018 Aug 06, 2018	SELL	$6.91 - $9.55 $94,335 - $130,376	-13,652 Reduced 14.68%	79,341 $683,000
Q1 2018 May 15, 2018	BUY	$7.34 - $11.16 $72,688 - $110,517	9,903 Added 11.92%	92,993 $682,000
Q4 2017 Feb 09, 2018	BUY	$9.15 - $12.64 $760,273 - $1.05 Million	83,090	83,090 $842,000

Others Institutions Holding MCRB

# of Institutions

100

Shares Held

62.7M

Call Options Held

36.9K

Put Options Held

476K

Flagship Pioneering Inc. Cambridge, MA

23.1M
Shares

$16.6 Million
1.17% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$4.91 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.73M
Shares

$4.85 Million
0.0% of portfolio
Hudson Bay Capital Management LP Greenwich, CT

5.43M
Shares

$3.91 Million
0.03% of portfolio
Geode Capital Management, LLC Boston, MA

2.13M
Shares

$1.54 Million
0.0% of portfolio

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account